Showing results (81-90 of 129) with videos related to
Sort By:
Pageof 13
Analytical Chemistry|November 16, 2019
In Vivo Large-Scale Mapping of Protein Turnover in Human Cerebrospinal FluidSylvain Lehmann, Christophe Hirtz, Jérôme Vialaret, et al.International Journal of Clinical Oncology|May 20, 2024
Prediction of response to promising first-line chemotherapy in ovarian cancer patients with residual peritoneal tumors: practical biomarkers and robust multiplex modelsReika Kawabata-Iwakawa, Norihiro Iwasa, Kenichi Satoh, et al.Nucleic Acids Research|December 6, 2011
neXtProt: a knowledge platform for human proteinsLydie Lane, Ghislaine Argoud-Puy, Aurore Britan, et al.Journal of Proteome Research|May 8, 2014
Comprehensive comparative and semiquantitative proteome of a very low number of native and matched epstein-barr-virus-transformed B lymphocytes infiltrating human melanomaMargarita Maurer, André C Müller, Katja Parapatics, et al.International Journal of Cancer|May 17, 2019
Distinct oncogenes drive different genome and epigenome alterations in human mammary epithelial cellsClaire Fonti, Anne Saumet, Amanda Abi-Khalil, et al.Plos One|September 21, 2011
Functional dissection of the TBK1 molecular networkAdriana Goncalves, Tilmann Bürckstümmer, Evelyn Dixit, et al.Theranostics|April 16, 2020
The molecular landscape and microenvironment of salivary duct carcinoma reveal new therapeutic opportunitiesMelissa Alame, Emmanuel Cornillot, Valère Cacheux, et al.The Journal of Experimental Medicine|November 17, 2010
CD14 is a coreceptor of Toll-like receptors 7 and 9Christoph L Baumann, Irene M Aspalter, Omar Sharif, et al.European Journal of Immunology|February 14, 2015
The RNA-binding protein HuR/ELAVL1 regulates IFN-β mRNA abundance and the type I IFN responseBarbara Herdy, Thomas Karonitsch, Gregory I Vladimer, et al.Plos One|October 17, 2013
A target-disease network model of second-generation BCR-ABL inhibitor action in Ph+ ALLUwe Rix, Jacques Colinge, Katharina Blatt, et al.Pageof 13